Degenerative Cervical Myelopathy Repository Study
This study is creating a collection of information (a repository) from people with degenerative cervical myelopathy (DCM), a condition where the spinal cord in the neck is compressed. It also includes a comparison group of people with neck problems that don't involve spinal cord compression. Researchers will collect information from your standard medical care, like imaging and lab results, to better understand DCM. The goal is to find ways to predict how DCM might progress and how well treatments work, and to develop a tool to predict outcomes after surgery for DCM. You could be eligible if you are between 18 and 100 years old and have either DCM or another cervical degenerative disease without myelopathy. The study aims to enroll 245 participants.
- Study design
- This is an observational study, meaning researchers will collect information from your regular medical care. It aims to include 245 participants.
- What's involved
- Researchers will collect information from your standard clinical care procedures and outcome measurements. This includes surgical interventions, imaging, laboratory results, and other measurements.
- Compensation
- Not stated in the trial record.
- Follow-up
- Data will be compared between groups at 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Degenerative Cervical Myelopathy Repository
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Francis Farhadi, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Kentucky
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Data comparison between DCM and control groups2 years
This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy.